Pretreatment Amide Proton Transfer‐Weighted Imaging Histogram Analysis Combined With ER ‐Negative and HER2 ‐Positive Expression Predicts Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer

Documenti analoghi

• Factors Influencing Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Single‐Center Retrospective Study Focusing on ER and HER‐2 Status
  di: Yadong Zhang, et al.
  Pubblicazione: (2026)
• Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple‐Negative Breast Cancer Patients
  di: Fengling Li, et al.
  Pubblicazione: (2024)
• Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple‐Negative Breast Cancer
  di: Zaida Morante, et al.
  Pubblicazione: (2025)
• Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response
  di: Milena Martello Cristófalo, et al.
  Pubblicazione: (2026)
• Letter to the Editor: Does Mammography Density Change the Response to Neoadjuvant Chemotherapy and Predict a Pathological Complete Response Rate?
  di: Qi Xu
  Pubblicazione: (2025)